Lv41
420 积分 2023-06-10 加入
Artificial intelligence in pharmaceutical administration and clinical pharmacy: A comprehensive review of advancements, challenges, and future directions
20天前
已关闭
Effects of CYP3A4 variants and drug–drug interactions on the metabolism of fexinidazole
3个月前
已完结
Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC–MS/MS
5个月前
已完结
Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients
5个月前
已完结
An Liquid Chromatography–Tandem Mass Spectrometry Method for the Simultaneous Determination of Afatinib, Alectinib, Ceritinib, Crizotinib, Dacomitinib, Erlotinib, Gefitinib, and Osimertinib in Human Serum
5个月前
已完结
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum – Application to therapeutic drug monitoring
5个月前
已完结
Determination of intracellular anlotinib, osimertinib, afatinib and gefitinib accumulations in human brain microvascular endothelial cells by liquid chromatography/tandem mass spectrometry
5个月前
已完结
Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum – Application to therapeutic drug monitoring
5个月前
已完结
Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum
5个月前
已完结
皖公网安备34019202002308
